Cargando…
APOE and TREM2 regulate amyloid responsive microglia in Alzheimer’s disease
Beta-amyloid deposition is a defining feature of Alzheimer’s disease (AD). How genetic risk factors, like APOE and TREM2, intersect with cellular responses to beta-amyloid in human tissues is not fully understood. Using single-nucleus RNA sequencing of postmortem human brain with varied APOE and TRE...
Autores principales: | Nguyen, Aivi T., Wang, Kui, Hu, Gang, Wang, Xuran, Miao, Zhen, Azevedo, Joshua A., Suh, EunRan, Van Deerlin, Vivianna M., Choi, David, Roeder, Kathryn, Li, Mingyao, Lee, Edward B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7520051/ https://www.ncbi.nlm.nih.gov/pubmed/32840654 http://dx.doi.org/10.1007/s00401-020-02200-3 |
Ejemplares similares
-
Elevating microglia TREM2 reduces amyloid seeding and suppresses disease-associated microglia
por: Zhao, Na, et al.
Publicado: (2022) -
TREM2-Dependent Effects on Microglia in Alzheimer’s Disease
por: Zhou, Yingyue, et al.
Publicado: (2018) -
Established Beta Amyloid Pathology Is Unaffected by TREM2 Elevation in Reactive Microglia in an Alzheimer’s Disease Mouse Model
por: Yuan, Qiuju, et al.
Publicado: (2021) -
Reduced TREM2 activation in microglia of patients with Alzheimer's disease
por: Okuzono, Yuumi, et al.
Publicado: (2021) -
TREM2 dependent and independent functions of microglia in Alzheimer’s disease
por: Hou, Jinchao, et al.
Publicado: (2022)